Skip to Main Content

Author Details

Cindy L Vnencak-Jones
Vanderbilt University Medical Center
1987
125
37
PMIDPaper TitleJournal TitlePublished Year
36450478Impairments to executive function in emerging adults with Huntington disease.J Neurol Neurosurg Psychiatry2023
37407326Preemptive Pharmacogenetic-Guided Metoprolol Management for Postoperative Atrial Fibrillation in Cardiac Surgery: The Preemptive Pharmacogenetic-Guided Metoprolol Management for Atrial Fibrillation in Cardiac Surgery Pilot Trial.J Cardiothorac Vasc Anesth2023
36503149Assessments of Somatic Variant Classification Using the Association for Molecular Pathology/American Society of Clinical Oncology/College of American Pathologists Guidelines: A Report from the Association for Molecular Pathology.J Mol Diagn2023
34240279The first report of a JAK2 V617F-positive myeloproliferative neoplasm with initial manifestation as a rare pampiniform venous plexus thrombosis and review of the literature.J Thromb Thrombolysis2022
33048353A Tutorial for Pharmacogenomics Implementation Through End-to-End Clinical Decision Support Based on Ten Years of Experience from PREDICT.Clin Pharmacol Ther2021
34834403Impact of Updating Pharmacogenetic Results: Lessons Learned from the PREDICT Program.J Pers Med2021
33283233Acute Myeloid Leukemia Case Harboring Unusual FLT3 Variant: Somatic vs Germline?Lab Med2021
31606278CYP2D6 Genotype-guided Metoprolol Therapy in Cardiac Surgery Patients: Rationale and Design of the Pharmacogenetic-guided Metoprolol Management for Postoperative Atrial Fibrillation in Cardiac Surgery (PREEMPTIVE) Pilot Study.J Cardiothorac Vasc Anesth2020
30543839Small Cell Lung Cancer Transformation as a Mechanism of Resistance to PD-1 Therapy in KRAS-Mutant Lung Adenocarcinoma: A Report of Two Cases.J Thorac Oncol2019
29875428The impact of variant classification on the clinical management of hereditary cancer syndromes.Genet Med2019
31184237Clinicopathologic correlates of <i>MYD88</i> L265P mutation and programmed cell death (PD-1) pathway in primary central nervous system lymphoma.Leuk Lymphoma2019
31152546PD-L1 Expression Patterns in Microsatellite Instability-High Intestinal Adenocarcinoma Subtypes.Am J Clin Pathol2019
29249244Authors' Reply.J Mol Diagn2018
29423539Clinical prognostic value of the isocitrate dehydrogenase 1 single-nucleotide polymorphism rs11554137 in glioblastoma.J Neurooncol2018
29474982Deciphering Elevated Microsatellite Alterations at Selected Tetra/Pentanucleotide Repeats, Microsatellite Instability, and Loss of Heterozygosity in Colorectal Cancers.J Mol Diagn2018
29310020Genotypic and clinical heterogeneity within NCCN favorable-risk acute myeloid leukemia.Leuk Res2018
27993330Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists.J Mol Diagn2017
28278720Comparison of BCR/ABL1 mRNA levels by quantitative real-time PCR in peripheral blood and bone marrow specimens of patients with chronic myelogenous leukemia.Leuk Lymphoma2017
27810331Differences in Microsatellite Instability Profiles between Endometrioid and Colorectal Cancers: A Potential Cause for False-Negative Results?J Mol Diagn2017
27753663Primary Carcinoid Tumor of the Renal Pelvis Arising From Intestinal Metaplasia: An Unusual Histogenetic Pathway?Appl Immunohistochem Mol Morphol2017
26732781Concurrent and Clonally Related Pediatric Follicular Lymphoma and Burkitt Lymphoma in a 5-Year-Old Boy.Lab Med2016
27284491Mutation profiles of synchronous colorectal cancers from a patient with Lynch syndrome suggest distinct oncogenic pathways.J Gastrointest Oncol2016
25801490Clonal evolution of acute myeloid leukemia relapsed after 19 years of remission.Am J Hematol2015
24186143Epidermal growth factor receptor signaling pathway is frequently altered in ampullary carcinoma at protein and genetic levels.Mod Pathol2014
31051723Molecular testing of NSCLC using a platform for rapid detection of multiple oncogenetic mutations.J Am Soc Cytopathol2014
25337215The ambiguous boundary between EBV-related hemophagocytic lymphohistiocytosis and systemic EBV-driven T cell lymphoproliferative disorder.Int J Clin Exp Pathol2014
25076300Transformation of small B-cell lymphoma into large cell CD30⁺, CD4⁺, Epstein-Barr virus-negative lymphoma.Arch Pathol Lab Med2014
24599935Beyond histology: translating tumor genotypes into clinically effective targeted therapies.Clin Cancer Res2014
24722917Characterization of breast cancers with PI3K mutations in an academic practice setting using SNaPshot profiling.Breast Cancer Res Treat2014
24651910Endomyometriosis ("Uterus-like mass") in an XY Male: Case Report With Molecular Confirmation and Literature Review.Int J Surg Pathol2014
24300538Lymphoepithelioma-like carcinoma of the endometrium: immunophenotypic characterization of a rare tumor with microsatellite instability testing.Int J Gynecol Pathol2014
23515407Characteristics of lung cancers harboring NRAS mutations.Clin Cancer Res2013
24345920BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibition.Clin Cancer Res2013
23949867Maternal FMR1 premutation allele expansion and contraction in fraternal twins.Am J Med Genet A2013
23773459Clinical utility of KRAS and BRAF mutations in a cohort of patients with colorectal neoplasms submitted for microsatellite instability testing.Clin Colorectal Cancer2013
22238169A comparison of 2 strategies to prevent infection following pertussis exposure in vaccinated healthcare personnel.Clin Infect Dis2012
22798288BRAF(L597) mutations in melanoma are associated with sensitivity to MEK inhibitors.Cancer Discov2012
22773810Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1.Proc Natl Acad Sci U S A2012
22536370Routine multiplex mutational profiling of melanomas enables enrollment in genotype-driven therapeutic trials.PLoS One2012
22588608Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project.Clin Pharmacol Ther2012
22659680Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers.Bone Marrow Transplant2012
21227397A platform for rapid detection of multiple oncogenic mutations with relevance to targeted therapy in non-small-cell lung cancer.J Mol Diagn2011
22180717Neuroendocrine and squamous colonic composite carcinoma: case report with molecular analysis.World J Gastroenterol2011
20022264Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: a placebo-controlled trial.J Heart Lung Transplant2010
20496075A novel BMPR2 mutation associated with pulmonary arterial hypertension in an octogenarian.Lung2010
19880300T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension.Respir Med2010
19531247Copy-number variation in BMPR2 is not associated with the pathogenesis of pulmonary arterial hypertension.BMC Med Genet2009
19582766Bone marrow engraftment studies.Curr Protoc Hum Genet2009
19797613Competency-based education for the molecular genetic pathology fellow: a report of the association for molecular pathology training and education committee.J Mol Diagn2009
19745614A B-cell lymphoma diagnosed in "floater" tissue: implications of the diagnosis and resolution of a laboratory error.Am J Med Sci2009
  • 1 - 50 of 125

Recommended Authors

Technical University of Munich
Career Start Year 1999
Number of shared co-authors 3
Northwestern University Feinberg School of Medicine
Career Start Year 1998
Number of shared co-authors 1
UNC School of Medicine, The University of North Carolina at Chapel Hill
Career Start Year 1998
Number of shared co-authors 4
Children's Hospital Los Angeles
Career Start Year 1997
Number of shared co-authors 6
Mayo Clinic
Career Start Year 1997
Number of shared co-authors 1
Harvard T.H. Chan School of Public Health
Career Start Year 1996
Number of shared co-authors 3
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 6
Hannover Medical School
Career Start Year 1994
Number of shared co-authors 0
Johns Hopkins University School of Medicine
Career Start Year 1992
Number of shared co-authors 3
Baylor College of Medicine
Career Start Year 1992
Number of shared co-authors 8
Mayo Clinic
Career Start Year 1992
Number of shared co-authors 9
Dartmouth Health and the Dartmouth Cancer Center, USA Geisel School of Medicine
Career Start Year 1990
Number of shared co-authors 3
Yale School of Medicine
Career Start Year 1989
Number of shared co-authors 1
Oregon Health and Science University
Career Start Year 1988
Number of shared co-authors 3
University of North Carolina at Chapel Hill
Career Start Year 1987
Number of shared co-authors 8
National Human Genome Research Institute, National Institutes of Health
Career Start Year 1987
Number of shared co-authors 6
New York NewYork-Presbyterian Hospital
Career Start Year 1986
Number of shared co-authors 0
Baylor College of Medicine
Career Start Year 1984
Number of shared co-authors 15
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1983
Number of shared co-authors 0
Baylor College of Medicine
Career Start Year 1982
Number of shared co-authors 9
CytoGnomix Inc.
Career Start Year 1981
Number of shared co-authors 1
National Cancer Institute
Career Start Year 1980
Number of shared co-authors 4
David Geffen School of Medicine, university of california los angeles
Career Start Year 1980
Number of shared co-authors 2
Baylor College of Medicine
Career Start Year 1979
Number of shared co-authors 5
Oregon Health & Science University (OHSU)
Career Start Year 1978
Number of shared co-authors 3
Mayo Clinic
Career Start Year 1978
Number of shared co-authors 4
University of Adelaide
Career Start Year 1977
Number of shared co-authors 0
Instituto de Salud Carlos III
Career Start Year 1975
Number of shared co-authors 1
University of Oklahoma
Career Start Year 1968
Number of shared co-authors 2
The Ohio State University Comprehensive Cancer Center
Career Start Year 1961
Number of shared co-authors 2

Collaborators

Vanderbilt University Medical Center
Co-authored papers 15
Co-authored papers 4
Vanderbilt University Medical Center
Co-authored papers 3
Children's Hospital of Philadelphia
Co-authored papers 3
Massachusetts General Hospital
Co-authored papers 3
University of Cincinnati College of Medicine
Co-authored papers 3
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Injury Prevention Research Center, University of North Carolina
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Center for Precision Medicine, Vanderbilt University Medical Center
Co-authored papers 2
Massachusetts General Hospital Cancer Center, Harvard Medical School
Co-authored papers 2
Rush University Cancer Center, Rush University Medical Center
Co-authored papers 2
Center for Precision Health, The University of Texas Health Science Center at Houston
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 2
Centene Center for Health Transformation, Centene Corporation
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 2
Vanderbilt University School of Medicine
Co-authored papers 2
National Institutes of Health
Co-authored papers 2
Massachusetts General Hospital
Co-authored papers 2
Rhode Island Hospital
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 1
MD Anderson Cancer Center
Co-authored papers 1
Nationwide Children's Hospital
Co-authored papers 1
Vanderbilt University Medical Center
Co-authored papers 1
Vanderbilt University Medical Center
Co-authored papers 1
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Co-authored papers 1